Odey Asset Management has sold its entire stake in biotechnology company Oxford BioDynamics, according to a stock exchange filing today (7 November).
The firm held a 17.9% stake in the company, the filing said, and notified the issuer of the sale on 7 November. Odey AM's stake was worth about £12.7m, as the firm has a market cap of £71.1m, according to data from Morningstar Direct. Odey Asset Management to wind down business Last week, Odey AM began the process of winding down its business, after the asset manager was plagued by scandal after claims of sexual assault were brought against its founder Crispin Odey.
To continue reading this article...
Join Investment Week for free
Signup and gain exclusive members-only insights - all free of charge!
- Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
- Get ahead of regulatory and technological changes affecting fund management
- Important and breaking news stories selected by the editors delivered straight to your inbox each day
- Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
- Be the first to hear about our extensive events schedule and awards programmes
